Can luteal regression be reversed?

por Telleria, Carlos M
Publicado 2006

Repopulation of Ovarian Cancer Cells After Chemotherapy

por Telleria, Carlos M.
Publicado 2013

Cancer cell repopulation after therapy: which is the mechanism?

por Prakash, Rewati, Telleria, Carlos M.
Publicado 2023

Exogenous estradiol enhances apoptosis in regressing post-partum rat corpora lutea possibly mediated by prolactin

por Goyeneche, Alicia A, Telleria, Carlos M
Publicado 2005

Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy

por Goyeneche, Alicia A, Telleria, Carlos M
Publicado 2012

Antiprogestins in gynecological diseases

por Goyeneche, Alicia A, Telleria, Carlos M
Publicado 2015

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir

por Subeha, Mahbuba R., Telleria, Carlos M.
Publicado 2020

The gold complex auranofin: new perspectives for cancer therapy

por Abdalbari, Farah H., Telleria, Carlos M.
Publicado 2021

The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination

por Ritch, Sabrina J., Telleria, Carlos M.
Publicado 2022

Luteal regression: a redefinition of the terms

por Bowen-Shauver, Jennifer M, Telleria, Carlos M
Publicado 2003

Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives

por Forgie, Benjamin N., Prakash, Rewati, Telleria, Carlos M.
Publicado 2022

Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2

por Goyeneche, Alicia A., Seidel, Erin E., Telleria, Carlos M.
Publicado 2011

Luteal 3beta-hydroxysteroid dehydrogenase and 20alpha-hydroxysteroid dehydrogenase activities in the rat corpus luteum of pseudopregnancy: Effect of the deciduoma reaction

por Clementi, Marisa A, Deis, Ricardo P, Telleria, Carlos M
Publicado 2004

Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin

por Kapperman, Heather E., Goyeneche, Alicia A., Telleria, Carlos M.
Publicado 2018

Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer Cells

por Wempe, Stacy L., Gamarra-Luques, Carlos D., Telleria, Carlos M.
Publicado 2013

Long-term primary culture of a clear cell ovarian carcinoma reveals an epithelial–mesenchymal cooperative interaction

por Goyeneche, Alicia A., Koch, Michael, Bell, Maria C., Telleria, Carlos M.
Publicado 2015

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity

por Freeburg, Elizabeth M, Goyeneche, Alicia A, Seidel, Erin E, Telleria, Carlos M
Publicado 2009

The celiac ganglion modulates LH-induced inhibition of androstenedione release in late pregnant rat ovaries

por Casais, Marilina, Delgado, Silvia M, Sosa, Zulema, Telleria, Carlos M, Rastrilla, Ana M
Publicado 2006

Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity

por Gamarra-Luques, Carlos D, Hapon, Maria B, Goyeneche, Alicia A, Telleria, Carlos M
Publicado 2014

Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling

por Ritch, Sabrina J., Brandhagen, BreeAnn N., Goyeneche, Alicia A., Telleria, Carlos M.
Publicado 2019